2019 American Transplant Congress
Redefining Cirrhotic Cardiomyopathy; A Shifting Paradigm
*Purpose: Diastolic dysfunction (DD) is the hallmark of cirrhotic cardiomyopathy (CCM) for which criteria were established in 2005. Based on those criteria, the prevalence of…2019 American Transplant Congress
Five Years after Right Hepatectomy for Living Liver Donation: Donor State of Health
General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany
*Purpose: Of utmost importance in living liver donation is the avoidance of postoperative complications and reduction of quality of life of the donor.*Methods: Inclusion criteria…2019 American Transplant Congress
Ligation of the Proximal Splenic Vein to Keep Adequate Portal Flow in Patients with Large Splenorenal Shunts during Living Donor Liver Transplantation
*Purpose: Adequate graft portal venous flow is essential for the rapid regeneration of partial grafts during living donor liver transplantation (LDLT). Large splenorenal shunts (SRS)…2019 American Transplant Congress
Improving Pre-Kidney Transplantion Laboratory Utilization in an Era of Increasing Waitlist Size
*Purpose: Beginning on March 25, 2015, our institution’s kidney transplant program has implemented a “readiness” protocol, whereby patients are listed after limited workup and comprehensive…2019 American Transplant Congress
Soluble Fibrinogen-Like Protein 2 Regulates MDSCs Differentiation and Function in Allograft Immunity
Urology, Zhongshan Hospital, Fudan University, Shanghai, China
*Purpose: Soluble fibrinogen-like protein 2 (sFGL2) is a novel immunoregulatory molecule, secreted mainly by regulatory T cells. CD11b+ Gr1+ myeloid-derived suppressor cells (MDSCs) are an…2019 American Transplant Congress
Initial Peritoneal sST2 Levels Are Associated with Peritoneal Failure and ST2 Blockade Mitigates TGF-β and High Glucose-Induced Peritoneal Fibrosis
*Purpose: Peritoneal fibrosis (PF) is an intractable complication which leads to peritoneal membrane failure in peritoneal dialysis (PD). The aim of this study was to…2019 American Transplant Congress
Outcome of Renal Transplantation in Systemic Amyloidosis
*Purpose: Systemic amyloidosis accounts for approximately 0.8% of end stage renal disease (ESRD) in the UK. Outcomes following renal transplantation in systemic amyloidosis were historically…2019 American Transplant Congress
Tibetans and Hans Have Comparable Transplant Outcomes- A Propensity Score Matched Cohort Analysis
*Purpose: Tibetans is usually believed to have inferior clinical outcomes to Hans due to social economical and culture reasons. Limited data concerning kidney transplant (KT)…2019 American Transplant Congress
A National Cohort Validation of Graft Outcomes of Elderly Kidney Transplant Recipients
Henry Ford Transplant Institute, Detroit, MI
*Purpose: Previous analyses comparing elderly kidney transplant recipients (KTR) to younger KTR found that elderly patients suffered higher rates of mortality, less biopsy-proven acute rejection…2019 American Transplant Congress
Social Determinants of Quality of Life in Patients Evaluated for Kidney Transplant
*Purpose: Non-Hispanic African Americans (AA) have a higher incidence of ESRD but lower rates of kidney transplant (KT), and poorer quality of life (QOL) compared…
- « Previous Page
- 1
- …
- 207
- 208
- 209
- 210
- 211
- …
- 214
- Next Page »